# Parasite Clearance and Protection From Infection (PCPI) in Cameroon

> **NCT06173206** · PHASE3 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 902 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** SP (Macleods Pharmaceuticals Ltd)
- **DRUG:** SPAQ (Guilin Pharmaceuticals)
- **DRUG:** AS (Guilin Pharmaceuticals)

## Key facts

- **NCT ID:** NCT06173206
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-10
- **Primary completion:** 2024-12-25
- **Final completion:** 2025-03-05
- **Target enrollment:** 902 (ACTUAL)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06173206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06173206, "Parasite Clearance and Protection From Infection (PCPI) in Cameroon". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06173206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*